Sentences with phrase «anaplastic lymphoma»

A subset of ALCL tumors carries chromosomal aberrations involving the anaplastic lymphoma kinase (alk) gene on chromosome 2p23 resulting in ALK overexpression (2).

Anaplastic lymphoma kinase (ALK)-- positive anaplastic large cell lymphoma (ALCL) frequently carries the t (2; 5)(p23; q35) resulting in aberrant expression of chimeric nucleophosmin - ALK.

Activation of Mammalian Target of Rapamycin Signaling Pathway Contributes to Tumor Cell Survival in Anaplastic Lymphoma Kinase — Positive Anaplastic Large Cell Lymphoma

Anaplastic Large - Cell Lymphoma T Anaplastic Lymphoma Kinase - Positive Associated With Crohn's Disease Undergoing Treatment With Azathioprine: A Case Report

But the diagnostic test, which checks to see if a patient's tumor carries a mutation in a gene coding for anaplastic lymphoma kinase, called ALK, is just $ 250.

The advent of therapies directed at tumors with mutations in epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and B - Raf proto - oncogene (BRAF) genes over the past decade have dramatically changed outcomes, he says.

«Patients with non-small cell lung cancer (NSCLC) should receive front line therapy with the anaplastic lymphoma kinase (ALK) inhibitor crizotinib,» said lead author Professor Giorgio Scagliotti, head of the Department of Oncology, University of Turin, Italy.

Some patients with non-small cell lung cancer (NSCLC) have changes in the anaplastic lymphoma kinase (ALK) gene, which can drive the development of their cancer.

Multiplexed genetic screening for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) gene rearrangements and subsequent biomarker - guided treatment is cost - effective compared with standard chemotherapy treatment without any molecular testing in the metastatic non-small cell lung cancer (NSCLC) setting in the United States.

Of the more than 1,600 samples tested, 10.5 % had EGFR sensitizing, 18.8 % EGFR resistance, 13.2 % KRAS, and 2 % EML4 - ALK (anaplastic lymphoma kinase) mutations.

Not exact matches

Breast implant - associated anaplastic large cell lymphoma — or BIA - ALCL — is a rare peripheral T - cell lymphoma that may develop in patients with breast implants.

New Insights into Breast Implant - Associated Anaplastic Large - Cell Lymphoma News-Medical.net — March 28, 2018

Brentuximab vedotin was previously approved by the FDA to treat cHL after relapse, cHL after stem cell transplant when a patient is at a high risk of relapse or progression, systemic anaplastic large cell lymphoma (ALCL) after failure of other treatment, and primary cutaneous ALCL after failure of other treatment.

Anaplastic large cell lymphoma (ALCL) is an aggressive form of malignant lymphoma of T / null lineage (1).

In this interview we discuss the link between breast implants and anaplastic large - cell lymphoma, a rare type of T - cell lymphoma.

Pediatric patients with ALK - positive anaplastic large cell lymphomas and inflammatory myofibroblastic tumors had strong responses to treatment with crizotinib.

ONC201 demonstrated (GI50 1 - 8 µM) dose - and time - dependent efficacy in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), chronic lymphocytic leukemia (CLL), diffuse large B - cell lymphoma (DLBCL), mantle cell lymphoma (MCL), Burkitt's lymphoma, anaplastic large cell lymphoma (ALCL), cutaneous T - cell lymphoma (CTCL), Hodgkin's lymphoma (nodular sclerosis) and multiple myeloma (MM) cell lines including cells resistant to standard of care (dexamethasone in MM) and primary samples.

The cancer is anaplastic large cell lymphoma (ALCL), which impacts the cells around the implant.

On February 1st, after my first day at my new job, I was diagnosed with Lymphoma (anaplastic large cell alk negative; one of the rarer types of non-Hodgkin's lyLymphoma (anaplastic large cell alk negative; one of the rarer types of non-Hodgkin's lymphomalymphoma).